Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37688

KRT8 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The KRT8 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T human embryonic kidney epithelial cells, disrupting the KRT8 gene. Loss of keratin 8 abolishes type II intermediate filaments, impairing cytoskeletal organization, mechanical support, and epithelial barrier function. This model disrupts key apoptosis regulatory interactions: KRT8 normally sequesters the BH3?only protein Bim and modulates death receptor signaling through TNFR2 and Fas, so its removal sensitizes cells to apoptotic stimuli. Applications include immunofluorescence microscopy of keratin networks, Annexin V apoptosis assays, co?immunoprecipitation with KRT18, transwell migration, and drug sensitivity screening. For further details, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    KRT8

    Gene Identifier

    NCBI Gene ID 3856

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KRT8 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the human KRT8 gene in HEK293T cells. This heterogeneous population retains diverse editing events across cells, providing a robust and reproducible loss-of-function model without single-cell cloning biases.

The host HEK293T line is a human embryonic kidney epithelial cell line transformed with adenovirus 5 DNA and stably expressing the SV40 large T antigen. This confers exceptionally high transfection efficiency and supports episomal replication, making it a workhorse for viral packaging and recombinant protein production. Its epithelial origin offers a relevant context for investigating keratin biology.

KRT8 encodes keratin 8, a type II intermediate filament protein that obligately pairs with KRT18 to form heterodimers. These filaments confer mechanical resilience by linking desmosomes and hemidesmosomes through interactions with desmoplakin, plakoglobin, and plectin. Transcription is controlled by p63 and Notch1, with further regulation by AP-1 factors downstream of EGF, TGF-??, PKC, and Akt. Functionally, KRT8 suppresses apoptosis by sequestering the BH3-only protein Bim and modulating death receptor signaling via TNFR2 and Fas. KRT8 loss disrupts keratin networks, releases Bim, and sensitizes cells to apoptotic stimuli while impairing epithelial barrier integrity.

In HEK293T cells, KRT8 knockout decouples keratin function from complex tissue architecture, enabling focused dissection of its anti-apoptotic role. The high transfectability allows efficient rescue experiments, mutant expression, or additional gene targeting, facilitating structure?function studies of the KRT8 interactome. The model is particularly suited for analyzing the Bim/Fas/TNFR2 signaling axis and for screening drugs that exploit keratin-dependent survival mechanisms in epithelial cancers.

Typical applications include immunofluorescence visualization of keratin collapse, Annexin V apoptosis assays, co?immunoprecipitation with KRT18, and transwell migration studies. Researchers employ mechanical stress assays and compound sensitivity profiling to model epithelial fragility disorders and drug?induced toxicity. Western blotting for KRT8 and KRT18 confirms knockout and monitors compensatory changes. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)